Melanoma patient study in France database
Part of Cancer, Skin clinical trials.
This study collects information from people with melanoma (skin cancer), at any stage. It may help researchers better understand melanoma and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with melanoma
- Your melanoma can be any stage (early or advanced)
- You agree to take part in the study
- You are not under court protection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a registry that collects information from people diagnosed with an invasive skin melanoma. It may help researchers understand who gets melanoma and how it’s diagnosed and treated over time.
This study follows adults with certain melanoma stages to better understand the disease over time. You may be asked to share tissue samples (if available) so researchers can study tumor biology and track outcomes.
This study looks at immune and tumor “behavior” markers in people with metastatic melanoma after standard treatment. It may help researchers understand why treatment works for some people and not others by testing blood and skin tumor samples.
This research study analyzes blood and tissue samples from melanoma patients to identify biological markers that could help doctors better understand and treat the disease. Researchers will examine archived tissue samples and blood work to develop improved diagnostic tools.
This study collects data and samples from people with skin cancer and healthy volunteers to help research. It may be a way to contribute to future treatments.
This study aims to find better ways to treat melanoma in children, teenagers, and young adults. It may help improve care for patients under 30 years old with certain types of skin growths.
Hear when a new Melanoma (Skin) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.